Anna Galstyan
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
- Characterization and Applications of Magnetic Nanoparticles
- Graphene and Nanomaterials Applications
Papers in
-
- RNA Interference and Gene Delivery 5
-
- Nanoparticle-Based Drug Delivery 4
- Supramolecular Self-Assembly in Materials 2
- Co-authors
- Julia Y. Ljubimova (12 shared papers)Eggehard Holler (11 shared papers)Liron L. Israel (5 shared papers)Keith L. Black (9 shared papers)Antonella Chiechi (6 shared papers)Ekaterina S. Shatalova (7 shared papers)Rameshwar Patil (8 shared papers)Hui Ding (6 shared papers)
- Journals
- Journal of Controlled Release (3 papers)ACS Nano (2 papers)International Journal of Nanomedicine (1 paper)Cancer Research (1 paper)The Science of The Total Environment (1 paper)
- Partner nations
- United StatesGermanyPortugal
In The Last Decade
Anna Galstyan
13 papers receiving 577 citations
Peers
Comparison fields: 5 of 91
- Biomaterials 253
- Biomedical Engineering 236
- Neurology 38
- Health, Toxicology and Mutagenesis 66
- Genetics 41
Countries citing papers authored by Anna Galstyan
This map shows the geographic impact of Anna Galstyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Galstyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Galstyan more than expected).
Fields of papers citing papers by Anna Galstyan
This network shows the impact of papers produced by Anna Galstyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Galstyan. The network helps show where Anna Galstyan may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Galstyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 245 | |
| 2 | 2019 | 71 | |
| 3 | 2018 | 56 | |
| 4 | 2016 | 42 | |
| 5 | 2019 | 39 | |
| 6 | 2016 | 31 | |
| 7 | 2019 | 27 | |
| 8 | 2022 | 27 | |
| 9 | 2020 | 19 | |
| 10 | 2023 | 15 | |
| 11 | 2017 | 5 | |
| 12 | 2024 | 2 | |
| 13 | 2019 | 1 |
About Anna Galstyan
Anna Galstyan is a scholar working on Molecular Biology, Biomaterials, Genetics, Health, Toxicology and Mutagenesis and Physiology, having authored 13 papers that have together received 580 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Alzheimer's disease research and treatments (2 papers), Supramolecular Self-Assembly in Materials (2 papers), Air Quality and Health Impacts (2 papers), Glioma Diagnosis and Treatment (2 papers), Cancer Cells and Metastasis (1 paper) and Mental Health and Psychiatry (1 paper). The work is most often cited by research in Biomaterials (253 citations), Biomedical Engineering (236 citations), Neurology (38 citations), Health, Toxicology and Mutagenesis (66 citations) and Genetics (41 citations). Anna Galstyan has collaborated with scholars based in United States, Germany and Portugal. Frequent co-authors include Julia Y. Ljubimova, Eggehard Holler, Liron L. Israel, Keith L. Black, Antonella Chiechi, Ekaterina S. Shatalova, Rameshwar Patil, Hui Ding, Zachary B. Grodzinski and Oliver Braubach. Their work appears in journals such as Journal of Controlled Release, ACS Nano, International Journal of Nanomedicine, Cancer Research and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.